DOI QR코드

DOI QR Code

A Clinical Study for the Efficacy and Safety of Functional Cosmetics Containing Humulus japonicus Extract in Patients with Dry Skin due to Mild Atopic Dermatitis

아토피성 피부로 건조함을 가진 대상자에 대한 환삼덩굴추출물 함유 기능성 화장품의 유효성 및 안전성을 평가하기 위한 임상적 연구

  • Park, Hye-Su (Dept. of Korean Medical Ophthalmology & Otolaryngology & Dermatology, College of Korean Medicine, Semyung University) ;
  • Kim, Yong-Min (Dept. of Cosmetic Science & Beauty Biotechnology, Semyung University) ;
  • Kim, Hee-Tack (Dept. of Korean Medical Ophthalmology & Otolaryngology & Dermatology, College of Korean Medicine, Semyung University)
  • 박혜수 (세명대학교 한의과대학 한방안이비인후피부과학교실) ;
  • 김용민 (세명대학교 한방화장품과학과) ;
  • 김희택 (세명대학교 한의과대학 한방안이비인후피부과학교실)
  • Received : 2019.04.05
  • Accepted : 2019.05.02
  • Published : 2019.05.25

Abstract

Objectives : The purpose of this study is to confirm the Efficacy and Safety of "Functional cosmetics containing Humulus japonicus Extract" on dry skin due to mild atopic dermatitis. Methods : A total of 48 patients who visited Semyung Oriental Medical Center from March 20th, 2018 to July 5th, 2018 were included in the study. In this study, the patients were treated with Functional cosmetics containing Humulus japonicus Extract and positive control group. For 6 weeks of gross examination, instrumental assessment were made before and after the study to evaluate how well the products for treatment group with positive control products for control group in recovering the dry skin barriers by mild atopic dermatitis. Results : 1. In the primary endpoint, Skin Hydration showed a statistically significant increase and Transepidermal Water Loss(TEWL) showed a statistically significant decrease in treatment group between Baseline and 6 weeks. 2. In the secondary endpoint, Skin Hydration showed a statistically significant increase in treatment group between Baseline and 3 weeks, but TEWL showed no statistical significance. 3. In the secondary endpoint, Skin Hydration showed a statistically significant increase in treatment group between 3 weeks and 6 weeks, but TEWL showed no statistical significance. 4. In the secondary endpoint, Change of Skin Hydration and TEWL between treatment and control group showed a statistical significance in 6 weeks. 5. In the secondary endpoint, Change of Skin Hydration of 1cm below the medial aspect of the elbow between treatment and control group showed a statistical significance in 3 weeks. 6. In the secondary endpoint, Change of Skin Hydration between treatment and control group showed a statistical significance in 3 weeks and 6 weeks except Center between the medial aspect of the elbow and the wrist in 3 weeks, and Change of TEWL between treatment and control group showed a statistical significance in 6 weeks. 7. To evaluate the safety of the products for the human body, Adverse events, EASI Score, Itching Symptoms Assessment, vital sign check were conducted; There were no severe adverse events during this study. And both experimental group and control group showed no abnormal level. Therefore, it is suggested that products, if used for certain period, should be safe for the human body. Conclusions : According to the above experiments, it is suggested that "Functional cosmetics containing Humulus japonicus Extract" should be effective for dry skin due to mild atopic dermatitis.

Keywords

OOBHC1_2019_v32n2_24_f0001.png 이미지

Fig. 1. Change of Skin Hydration between Treatment Group and Control Group in Baseline and 6 weeks(1㎝ below the medial aspect of the elbow)

OOBHC1_2019_v32n2_24_f0002.png 이미지

Fig. 2. Change of Skin Hydration between Treatment Group and Control Group in Baseline and 6 weeks(Center between the medial aspect of the elbow and the wrist)

OOBHC1_2019_v32n2_24_f0003.png 이미지

Fig. 3. Change of Transepidermal Water Loss (TEWL) between Treatment Group and Control Group in Baseline and 6 weeks(1㎝ below the medial aspect of the elbow)

OOBHC1_2019_v32n2_24_f0004.png 이미지

Fig. 4. Change of Transepidermal Water Loss TEWL) between Treatment Group and Control Group in Baseline and 6 weeks Center between the medial aspect of the elbow and the wrist)

Table 1. Composition of PB301 lotion and Positive Control

OOBHC1_2019_v32n2_24_t0001.png 이미지

Table 2. Schedule of Clinical Trial

OOBHC1_2019_v32n2_24_t0002.png 이미지

Table 3. Distribution Chart of Participants

OOBHC1_2019_v32n2_24_t0003.png 이미지

Table 4. Distribution of Sex, Antecedent Drug, Age, Height and Weight

OOBHC1_2019_v32n2_24_t0042.png 이미지

Table 5. Change of Skin Hydration between Baseline and 6 weeks(1㎝ below the medial aspect of the elbow)

OOBHC1_2019_v32n2_24_t0043.png 이미지

Table 6. Change of Skin Hydration between Baseline and 6 weeks(Center between the medial aspect of the elbow and the wrist)

OOBHC1_2019_v32n2_24_t0044.png 이미지

Table 7. Change of Transepidermal Water Loss(TEWL) between Baseline and 6 weeks(1㎝ below the medial aspect of the elbow)

OOBHC1_2019_v32n2_24_t0045.png 이미지

Table 8. Change of Transepidermal Water Loss(TEWL) between Baseline and 6 weeks(Center between the medial aspect of the elbow and the wrist)

OOBHC1_2019_v32n2_24_t0046.png 이미지

Table 9. Change of Skin Hydration in Treatment Group between Baseline and 3 weeks(1㎝ below the medial aspect of the elbow)

OOBHC1_2019_v32n2_24_t0047.png 이미지

Table 10. Change of Skin Hydration in Treatment Group between Baseline and 3 weeks(Center between the medial aspect of the elbow and the wrist)

OOBHC1_2019_v32n2_24_t0048.png 이미지

Table 11. Change of Transepidermal Water Loss(TEWL) in Treatment Group between Baseline and 3 weeks(1㎝ below the medial aspect of the elbow)

OOBHC1_2019_v32n2_24_t0049.png 이미지

Table 12. Change of Transepidermal Water Loss(TEWL) in Treatment Group between Baseline and 3 weeks(Center between the medial aspect of the elbow and the wrist)

OOBHC1_2019_v32n2_24_t0050.png 이미지

Table 13. Change of Skin Hydration in Treatment Group between 3 weeks and 6 weeks(1㎝ below the medial aspect of the elbow)

OOBHC1_2019_v32n2_24_t0051.png 이미지

Table 14. Change of Skin Hydration in Treatment Group between 3 weeks and 6 weeks(Center between the medial aspect of the elbow and the wrist)

OOBHC1_2019_v32n2_24_t0052.png 이미지

Table 15. Change of Transepidermal Water Loss(TEWL) in Treatment Group between 3 weeks and 6 weeks(1㎝ below the medial aspect of the elbow)

OOBHC1_2019_v32n2_24_t0053.png 이미지

Table 16. Change of Transepidermal Water Loss(TEWL) in Treatment Group between 3 weeks and 6 weeks(Center between the medial aspect of the elbow and the wrist)

OOBHC1_2019_v32n2_24_t0054.png 이미지

Table 17. Change of Skin Hydration between Treatment Group and Control Group in Baseline and 6 weeks(1㎝ below the medial aspect of the elbow)

OOBHC1_2019_v32n2_24_t0055.png 이미지

Table 18. Change of Skin Hydration between Treatment Group and Control Group in Baseline and 6 weeks(Center between the medial aspect of the elbow and the wrist)

OOBHC1_2019_v32n2_24_t0056.png 이미지

Table 19. Change of Transepidermal Water Loss(TEWL) between Treatment Group and Control Group in Baseline and 6 weeks(1㎝ below the medial aspect of the elbow)

OOBHC1_2019_v32n2_24_t0057.png 이미지

Table 20. Change of Transepidermal Water Loss(TEWL) between Treatment Group and Control Group in Baseline and 6 weeks(Center between the medial aspect of the elbow and the wrist)

OOBHC1_2019_v32n2_24_t0058.png 이미지

Table 21. Change of Skin Hydration between Treatment Group and Control Group in Baseline and 3 weeks(1㎝ below the medial aspect of the elbow)

OOBHC1_2019_v32n2_24_t0059.png 이미지

Table 22. Change of Skin Hydration between Treatment Group and Control Group in Baseline and 3 weeks(Center between the medial aspect of the elbow and the wrist)

OOBHC1_2019_v32n2_24_t0060.png 이미지

Table 23. Change of Transepidermal Water Loss(TEWL) between Treatment Group and Control Group in Baseline and 3 weeks(1㎝ below the medial aspect of the elbow)

OOBHC1_2019_v32n2_24_t0061.png 이미지

Table 24. Change of Transepidermal Water Loss(TEWL) between Treatment Group and Control Group in Baseline and 3 weeks(Center between the medial aspect of the elbow and the wrist)

OOBHC1_2019_v32n2_24_t0062.png 이미지

Table 25. Change of Skin Hydration between Treatment Group and Control Group in 3 weeks and 6 weeks(1㎝ below the medial aspect of the elbow)

OOBHC1_2019_v32n2_24_t0063.png 이미지

Table 28. Change of Transepidermal Water Loss(TEWL) between Treatment Group and Control Group in 3 weeks and 6 weeks(Center between the medial aspect of the elbow and the wrist)

OOBHC1_2019_v32n2_24_t0064.png 이미지

Table 29. Change of Skin Hydration between Treatment Group and Control Group in Baseline, 3 weeks and 6 weeks(1㎝ below the medial aspect of the elbow)

OOBHC1_2019_v32n2_24_t0065.png 이미지

Table 26. Change of Skin Hydration between Treatment Group and Control Group in 3 weeks and 6 weeks(Center between the medial aspect of the elbow and the wrist)

OOBHC1_2019_v32n2_24_t0066.png 이미지

Table 27. Change of Transepidermal Water Loss(TEWL) between Treatment Group and Control Group in 3 weeks and 6 weeks(1㎝ below the medial aspect of the elbow)

OOBHC1_2019_v32n2_24_t0067.png 이미지

Table 30. Change of Skin Hydration between Treatment Group and Control Group in Baseline, 3 weeks and 6 weeks(Center between the medial aspect of the elbow and the wrist)

OOBHC1_2019_v32n2_24_t0068.png 이미지

Table 31. Change of Transepidermal Water Loss(TEWL) between Treatment Group and Control Group in Baseline, 3 weeks and 6 weeks(1㎝ below the medial aspect of the elbow)

OOBHC1_2019_v32n2_24_t0069.png 이미지

Table 32. Change of Transepidermal Water Loss(TEWL) between Treatment Group and Control Group in Baseline, 3 weeks and 6 weeks(Center between the medial aspect of the elbow and the wrist)

OOBHC1_2019_v32n2_24_t0070.png 이미지

Table 33. Adverse Events

OOBHC1_2019_v32n2_24_t0071.png 이미지

Table 34. Change of EASI Score

OOBHC1_2019_v32n2_24_t0072.png 이미지

Table 35. Change of itching Symptoms

OOBHC1_2019_v32n2_24_t0073.png 이미지

Table 36. Change of the Frequency of Itching Symptoms

OOBHC1_2019_v32n2_24_t0074.png 이미지

Table 37. Change of the Duration of itching Symptoms

OOBHC1_2019_v32n2_24_t0075.png 이미지

Table 38. Change of Systolic Blood Pressure

OOBHC1_2019_v32n2_24_t0076.png 이미지

Table 39. Change of Diastolic Blood Pressure

OOBHC1_2019_v32n2_24_t0077.png 이미지

Table 40. Change of Pulse

OOBHC1_2019_v32n2_24_t0078.png 이미지

Table 41. Change of Body Temperature

OOBHC1_2019_v32n2_24_t0079.png 이미지

References

  1. Kim HJ. Refractory Atopic Dermatitis. 2016 KAAACI Annual Spring Congress: New Paradigms in Allergic Diseases. 2016:255-62.
  2. Hatakka K, Piirainen L, Pohjavuori S, Poussa T, Savilahti E, Korpela R. Allergy in day care children: prevalence and environmental risk factors. Acta Paediatr. 2009;98(5):817-22. https://doi.org/10.1111/j.1651-2227.2008.01198.x
  3. De Bruin Weller MS, Knulst AC, Meijer Y, Bruijnzeel-Koomen CA, Pasmans SG. Evaluation of the child with atopic dermatitis. Clin Exp Allergy. 2012;42(3):352-62. https://doi.org/10.1111/j.1365-2222.2011.03899.x
  4. Maheswaran D, Zeng Y, Chan-Yeung M, Scott J, Osornio-Vargas A, Becker AB, et al. Exposure to Beta-(1,3)-D-glucan in house dust at age 7-10 is associated with airway hyperresponsiveness and atopic asthma by age 11-14. PLoS One. 2014;9(6):1-11.
  5. Ahn SK, Jang KH, Kim TH, Jeong J, Cheon SH, Kang YC, et al. Common Skin Disease. 3rd ed. Seoul:Jeong Woo Medical Book. 2015:75-111.
  6. Kang MS, Kim JB, Kim HT. A Clinical Study for the Effect of External Applications Containing Herbal Extracts on Mild Atopic Dermatitis Patients. J Korean Med Ophthalmol Otolaryngol Dermatol. 2014;27(3):40-55. https://doi.org/10.6114/jkood.2014.27.3.040
  7. Kang MS, Kim YM, Kim HT. A Clinical Study for Moisturizing Effects of Herbal Cosmetics Containing Sinhyotakrisan Extracts. J Korean Med Ophthalmol Otolaryngol Dermatol. 2016;29(1):81-92. https://doi.org/10.6114/jkood.2016.29.1.081
  8. O MJ, Yoo YB, Lim SH, Kim HT. A Clinical study for the effect of ointment contained Takrisodok-Eum on recovering the damaged skin barrier by Atopic dermatitis. J Korean Med Ophthalmol Otolaryngol Dermatol. 2011;24(3):84-107. https://doi.org/10.6114/JKOOD.2011.24.3.084
  9. Lee JW, Go GY, Jung CH, You SJ, Kim YH, Ahn TW. Effect of DOGO phreatic weter containing germanium on Atopic Dermatitis in NC/Nga mouse. J Korean Med Ophthalmol Otolaryngol Dermatol. 2014;27(4):141-57. https://doi.org/10.6114/jkood.2014.27.4.141
  10. Son KJ, Park JH, Kim YH, Go GY, Kim YJ, Han JY, et al. Anti-atopic Effect of Chamaecyparis Obtusa oil (CHO_O) in DNCB-induced atopic dermatitis-like skin lesions NC/Nga mice. J Korean Med Ophthalmol Otolaryngol Dermatol. 2016;29(1):33-46. https://doi.org/10.6114/JKOOD.2016.29.1.033
  11. Kim JC, Hong SU. The Effects of Ionized Maifanite on Skin Damages of Nc/Nga Mice after Atopic Dermatitis Elicitation. J Korean Med Ophthalmol Otolaryngol Dermatol. 2007;30(1):29-42. https://doi.org/10.6114/JKOOD.2017.30.1.029
  12. Jung HJ, Hwang-Bo M, Do EJ, Suk JM, Kim MR, Kim YH, et al. A Clinical Research about Herbal Cosmetics Containing Phellinus linteus Extracts in Atopic Dermatitis Patients. J Korean Med Ophthalmol Otolaryngol Dermatol. 2010;23(3):154-64.
  13. Hwang SY, Jo MJ, Kim SC, Jee SY. Anti-inflammatory effects of the MeOH extract of Humulus japonicus in vivo. J Korean Med Ophthalmol Otolaryngol Dermatol. 2009;22(2):92-103.
  14. Sin MK. Clinical Traditional Herbalogy. Seoul:Younglimsa. 1997:449-50.
  15. Hur JY, Jeong CH, Shim KH. Chemical Components of Humulus japonicus Leaves and Stalks. J. Agriculture & Life Sciences. 2003;37(1):1-7.
  16. Lim DB, Lee YJ. The Effect of Humulus japonicus on Analgesia, Anti-inflammation, and Urination. J. of Herbology. 1993;8(1):69-75.
  17. Lee HS. Preventive effect and mechanism of Humulus japonicus extract on obesity. Major in Pharmacology. The Graduate School of Chung-Ang University. 2017.
  18. Hong SM. Beneficial effect of Humulus japonicus extract on hyperlipidemia and fatty liver induced by high fat diet obesity. Major in Pharmacology, Department of Medicine. The Graduate school of Chung-Ang University. 2014.
  19. Hwang SY. Anti-inflammaory effects of the MeOH extract of Humulus japonicus in vivo and in vitro. Department of Oriental Medicine. Graduate school of Daegu Haany University, Daegu, Korea. 2008.
  20. Park SW, Chung SK, Park JC. Active Oxygen Scavenging Activity of Luteolin-7-O-${\beta}$-D-Glucoside Isolated from Humulus japonicus. J. Korean. Soc. Food. Sci, Nutr. 2000;29(1):106-10.
  21. Lee SH. The Protective Effect of Humulus japonicus Extracts on Ethanol-Induced Chronic Hepatotoxicity in Rats. Major in Health, Social & Clinical Pharmacy Dept. of Pharmacology. The Graduate school Chung-Ang University. 2017.
  22. Moon SH. Studies of the effects of Humuli Herba on rats with nephritis induced by LPS. Dept. of Oriental medicine. Graduate School of Kyungwon University. 2008.
  23. Lee JH, Lee KC, Ha DH, Son IH, Lee WB, Oh YK, et al. Effect of Herba Humuli on the Cardiotoxicity Mediated by Methotrexate in Clutured Myocardial cells. Korean J. Oriental Medical Physiology & Pathology. 2001;15(4):585-9.
  24. KDA Textbook Editing Board. Textbook of Dermatology. 6th edition. Seoul:medbook. 2014:202-13.
  25. Gong NM, Jee SY. A Literature study about comparison of Eastern-Western medicine on the Atopic dermatitis. J Korean Med Ophthalmol Otolaryngol Dermatol. 1999;12(1):241-53.
  26. Heo J. A new Translation Donguibogam. Seoul:Bubin Publishers Co. 2005:769,3565.
  27. Do HK. Myeonguibyeolrok. Bejing: Inminwisaeng Publishing, Inc. 1986:165.
  28. Hwang SY, Jung HJ, Jang WS, Jo MJ, Kim SC, Jee SY. Anti-inflammatory effects of the MeOH extract of Humulus japonicus in vitro. J Korean Med Ophthalmol Otolaryngol Dermatol. 2009;22(3):71-9.
  29. Hong MS, Son ES, Lee SJ, Lee SK, Lee YJ, Song SD. Anti-mycobacterial Effects of the Extract of Humulus japonicus. Korean Journal of Food Science and Technology. 2014;46(1):94-9. https://doi.org/10.9721/KJFST.2014.46.1.94
  30. Lee YR, Kim KY, Lee SH, Kim MY, Park HJ, Jeong HS. Antioxidant and Antitumor Activities of Methanolic Extracts from Humulus japonicus. Korean Journal of Food and Nutririon. 2012;25(2):357-61. https://doi.org/10.9799/ksfan.2012.25.2.357